Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial

Figure 4

(a) A 47-year-old female patient with three refractory patches on the dorsal aspect of her right forearm, before treatment, (b) two months after treatment by microneedling plus topical pimecrolimus 1% on the pointed lesion (the largest lesion of the three), (c) three months after treatment with same procedure, and (d) at six months’ follow-up after treatment.